DE69927936D1 - Präventiva/mittel zur glaukombehandlung - Google Patents
Präventiva/mittel zur glaukombehandlungInfo
- Publication number
- DE69927936D1 DE69927936D1 DE69927936T DE69927936T DE69927936D1 DE 69927936 D1 DE69927936 D1 DE 69927936D1 DE 69927936 T DE69927936 T DE 69927936T DE 69927936 T DE69927936 T DE 69927936T DE 69927936 D1 DE69927936 D1 DE 69927936D1
- Authority
- DE
- Germany
- Prior art keywords
- glaucoma
- treatment
- prophylaxis
- agent
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP24776298 | 1998-08-17 | ||
JP24776298 | 1998-08-17 | ||
JP12296099 | 1999-04-28 | ||
JP12296099 | 1999-04-28 | ||
PCT/JP1999/004403 WO2000009162A1 (fr) | 1998-08-17 | 1999-08-13 | Medicaments preventifs/curatifs pour le glaucome |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69927936D1 true DE69927936D1 (de) | 2005-12-01 |
DE69927936T2 DE69927936T2 (de) | 2006-06-29 |
Family
ID=26459997
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69927936T Expired - Lifetime DE69927936T2 (de) | 1998-08-17 | 1999-08-13 | Präventiva/mittel zur glaukombehandlung |
Country Status (12)
Country | Link |
---|---|
US (2) | US6673812B1 (de) |
EP (3) | EP1459743B9 (de) |
JP (2) | JP3720264B2 (de) |
KR (1) | KR100616466B1 (de) |
CN (2) | CN1195547C (de) |
AT (3) | ATE529102T1 (de) |
AU (1) | AU5198199A (de) |
CA (2) | CA2307285C (de) |
DE (1) | DE69927936T2 (de) |
ES (3) | ES2247822T3 (de) |
HK (3) | HK1069120A1 (de) |
WO (1) | WO2000009162A1 (de) |
Families Citing this family (81)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100396171B1 (ko) * | 1998-08-10 | 2003-08-27 | 아사히 가세이 가부시키가이샤 | 염산 파수딜의 경구 서방성 제제 |
AU3196900A (en) * | 1999-03-25 | 2000-10-16 | Welfide Corporation | Preventives/remedies for interstitial pneumonia and pulmonary fibrosis |
AU3328600A (en) * | 1999-03-25 | 2000-10-16 | Santen Pharmaceutical Co. Ltd. | Ocular tension-lowering agents |
US9603741B2 (en) | 2000-05-19 | 2017-03-28 | Michael S. Berlin | Delivery system and method of use for the eye |
AU2001293817A1 (en) | 2000-09-20 | 2002-04-02 | Merck Patent Gmbh | 4-amino-quinazolines |
CN101310771B (zh) * | 2001-04-11 | 2012-08-08 | 千寿制药株式会社 | 视觉功能障碍改善剂 |
JP2003010158A (ja) * | 2001-04-26 | 2003-01-14 | Biochemical & Pharmacological Laboratories Inc | 眼精疲労モデル、その作製方法、そのモデルを用いた評価方法およびその評価法を用いて選択された薬剤 |
US7829566B2 (en) | 2001-09-17 | 2010-11-09 | Werner Mederski | 4-amino-quinazolines |
AU2003202263A1 (en) | 2002-01-10 | 2003-07-30 | Bayer Healthcare Ag | Roh-kinase inhibitors |
US6943172B2 (en) | 2002-01-23 | 2005-09-13 | Bayer Pharmaceuticals Corporation | Rho-kinase inhibitors |
CA2473510A1 (en) | 2002-01-23 | 2003-07-31 | Bayer Pharmaceuticals Corporation | Pyrimidine derivatives as rho-kinase inhibitors |
US7645878B2 (en) | 2002-03-22 | 2010-01-12 | Bayer Healthcare Llc | Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof |
GB0206860D0 (en) | 2002-03-22 | 2002-05-01 | Glaxo Group Ltd | Compounds |
ATE546143T1 (de) | 2002-08-29 | 2012-03-15 | Santen Pharmaceutical Co Ltd | Mittel zur behandlung von glaukom mit einem rho- kinase-hemmer und prostaglandinen |
AU2003269413A1 (en) * | 2002-11-01 | 2004-05-25 | Pharmacia & Upjohn Company Llc | Nicotinic acetylcholine agonists in the treatment of glaucoma and retinal neuropathy |
JP4314433B2 (ja) * | 2002-11-18 | 2009-08-19 | 参天製薬株式会社 | Rhoキナーゼ阻害剤とβ遮断薬からなる緑内障治療剤 |
US7160894B2 (en) * | 2003-06-06 | 2007-01-09 | Asahi Kasei Pharma Corporation | Tricyclic compound |
CN100390173C (zh) * | 2003-06-06 | 2008-05-28 | 旭化成制药株式会社 | 3环系化合物 |
JP4110324B2 (ja) | 2003-10-15 | 2008-07-02 | 宇部興産株式会社 | 新規インダゾール誘導体 |
US8415364B2 (en) | 2003-11-26 | 2013-04-09 | Duke University | Method of preventing or treating glaucoma |
WO2005079829A2 (en) * | 2004-02-18 | 2005-09-01 | Wisconsin Alumni Research Foundation | Method for treating glaucoma |
US20050222127A1 (en) * | 2004-03-30 | 2005-10-06 | Alcon, Inc. | Use of Rho kinase inhibitors in the treatment of hearing loss, tinnitus and improving body balance |
FR2868310A1 (fr) * | 2004-04-02 | 2005-10-07 | Oreal | Utilisation cosmetique d'au moins un inhibiteur de la production et/ou de l'activation des rhoa kinases comme agent destine a detendre les traits et/ou decontracter la peau |
CA2529613C (en) | 2004-06-03 | 2013-10-01 | Senju Pharmaceutical Co., Ltd. | Agent for repairing corneal sensitivity containing amide compound |
TWI367098B (en) | 2004-12-23 | 2012-07-01 | Kowa Co | Treating agent for glaucoma |
US20080269249A2 (en) * | 2004-12-27 | 2008-10-30 | Alcon, Inc. | Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases and conditions |
WO2006088088A1 (ja) * | 2005-02-16 | 2006-08-24 | Astellas Pharma Inc. | Rock阻害剤を含有する疼痛治療剤 |
JP4972551B2 (ja) * | 2005-06-21 | 2012-07-11 | 興和株式会社 | 緑内障の予防又は治療剤 |
WO2007007737A1 (ja) * | 2005-07-12 | 2007-01-18 | Kowa Co., Ltd. | 緑内障を予防又は治療する薬剤 |
CN101253152A (zh) | 2005-09-02 | 2008-08-27 | 安斯泰来制药株式会社 | 作为rock抑制剂的酰胺衍生物 |
US7867999B1 (en) | 2005-12-22 | 2011-01-11 | Alcon Research, Ltd. | Hydroxyamino- and amino-substituted pyridine analogs for treating rho kinase-mediated diseases and conditions |
US7655662B2 (en) | 2005-12-22 | 2010-02-02 | Alcon Research, Ltd. | (Indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)-pyrazines for treating glaucoma and controlling intraocular pressure |
TW200815398A (en) | 2006-06-08 | 2008-04-01 | Ube Industries | A novel indazole derivative having spirocyclic structure in the side chain |
CA2659687A1 (en) * | 2006-07-31 | 2008-02-07 | Senju Pharmaceutical Co., Ltd. | Aqueous liquid preparation containing amide compound |
US20100022517A1 (en) * | 2006-12-18 | 2010-01-28 | Richards Lori A | Ophthalmic formulation of rho kinase inhibitor compound |
AR064420A1 (es) * | 2006-12-21 | 2009-04-01 | Alcon Mfg Ltd | Composiciones farmaceuticas oftalmicas que comprenden una cantidad efectiva de analogos de 6-aminoimidazo[1,2b]piridazinas, utiles para el tratamiento del glaucoma y/o controlar la presion intraocular normal o elevada(iop). |
WO2008078762A1 (ja) | 2006-12-26 | 2008-07-03 | Santen Pharmaceutical Co., Ltd. | ウレア構造を有する新規n-(2-アミノフェニル)ベンズアミド誘導体 |
US20100056522A1 (en) | 2007-03-28 | 2010-03-04 | Santen Pharmaceutical Co., Ltd. | Intraocular pressure-lowering agent comprising compound having histone deacetylase inhibitor effect as active ingredient |
US8012972B2 (en) | 2007-03-28 | 2011-09-06 | Santen Pharmaceutical Co., Ltd. | Pyridinecarboxylic acid (2-aminophenyl) amide derivative having urea structure |
US20100190777A1 (en) | 2007-07-17 | 2010-07-29 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
CA2697895C (en) * | 2007-08-29 | 2017-10-31 | Senju Pharmaceutical Co., Ltd. | Agent for promoting corneal endothelial cell adhesion |
KR20140130725A (ko) * | 2007-09-21 | 2014-11-11 | 아이진 주식회사 | 트롬빈 유래 펩타이드를 포함하는 망막증 또는 녹내장 치료용 조성물 |
US20170360609A9 (en) | 2007-09-24 | 2017-12-21 | Ivantis, Inc. | Methods and devices for increasing aqueous humor outflow |
AU2009221859B2 (en) | 2008-03-05 | 2013-04-18 | Alcon Inc. | Methods and apparatus for treating glaucoma |
ES2389754T3 (es) | 2008-05-23 | 2012-10-31 | Santen Pharmaceutical Co., Ltd | Nuevos derivados de tiofendiamina con estructura urea |
KR20110042054A (ko) * | 2008-07-24 | 2011-04-22 | 고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 | 축성 근시의 예방 또는 치료제 |
EP2319514A4 (de) | 2008-07-25 | 2011-11-02 | Asahi Kasei Pharma Corp | Stabile wässrige lösungszusammensetzung mit einer sulfonamidverbindung |
US8273900B2 (en) | 2008-08-07 | 2012-09-25 | Novartis Ag | Organic compounds |
US20110166161A1 (en) * | 2008-09-18 | 2011-07-07 | Astellas Pharma Inc. | Heterocyclic carboxamide compounds |
US10272035B2 (en) * | 2008-11-13 | 2019-04-30 | Gholam A. Peyman | Ophthalmic drug delivery method |
US10842669B2 (en) | 2008-11-13 | 2020-11-24 | Gholam A. Peyman | Ophthalmic drug delivery method |
US20110125090A1 (en) * | 2008-11-13 | 2011-05-26 | Peyman Gholam A | Ophthalmic drug delivery system and method |
CR20170089A (es) | 2009-04-03 | 2017-07-17 | Plexxikon Inc | Composiciones del acido propano-1--sulfonico {3-[5-(4-cloro-fenil)-1h-pirrolo [2,3-b] piridina-3-carbonil] -2,4-difluoro-fenil}-amida y el uso de las mismas |
US8299079B2 (en) | 2009-05-22 | 2012-10-30 | Kaufman Herbert E | Preparations and methods for ameliorating or reducing presbyopia |
WO2010135731A1 (en) * | 2009-05-22 | 2010-11-25 | Kaufman Herbert E | Preparations and methods for ameliorating or reducing presbyopia |
CN102481404B (zh) | 2009-07-09 | 2014-03-05 | 伊万提斯公司 | 眼部植入物 |
EP2451375B1 (de) | 2009-07-09 | 2018-10-03 | Ivantis, Inc. | Einzelbedienervorrichtung zur verabreichung eines augenimplantats |
US8329724B2 (en) | 2009-08-03 | 2012-12-11 | Hoffmann-La Roche Inc. | Process for the manufacture of pharmaceutically active compounds |
WO2011021221A2 (en) | 2009-08-17 | 2011-02-24 | Reliance Life Sciences Pvt. Ltd. | Compositions for spinal cord injury |
NZ599866A (en) | 2009-11-06 | 2014-09-26 | Plexxikon Inc | Compounds and methods for kinase modulation, and indications therefor |
CA2803689A1 (en) * | 2010-07-27 | 2012-02-02 | Inspire Pharmaceuticals, Inc. | Method for treating ophthalmic diseases using kinase inhibitor compounds in prodrug forms |
TW201729813A (zh) | 2011-02-04 | 2017-09-01 | Kowa Co Ltd | 青光眼預防或治療之藥物療法 |
MA34948B1 (fr) | 2011-02-07 | 2014-03-01 | Plexxikon Inc | Composes et procedes de modulation de kinase, et leurs indications |
TWI558702B (zh) | 2011-02-21 | 2016-11-21 | 普雷辛肯公司 | 醫藥活性物質的固態形式 |
US8657776B2 (en) | 2011-06-14 | 2014-02-25 | Ivantis, Inc. | Ocular implants for delivery into the eye |
US8663150B2 (en) | 2011-12-19 | 2014-03-04 | Ivantis, Inc. | Delivering ocular implants into the eye |
US9358156B2 (en) | 2012-04-18 | 2016-06-07 | Invantis, Inc. | Ocular implants for delivery into an anterior chamber of the eye |
US9150570B2 (en) | 2012-05-31 | 2015-10-06 | Plexxikon Inc. | Synthesis of heterocyclic compounds |
TWI643619B (zh) * | 2012-07-13 | 2018-12-11 | 日商參天製藥股份有限公司 | 一種用於預防或治療青光眼或高眼壓症、或降低眼壓之醫藥組合物及其用途 |
US10617558B2 (en) | 2012-11-28 | 2020-04-14 | Ivantis, Inc. | Apparatus for delivering ocular implants into an anterior chamber of the eye |
CN105050600B (zh) | 2013-04-24 | 2018-09-28 | 国立大学法人九州大学 | 眼底疾病治疗剂 |
US10709547B2 (en) | 2014-07-14 | 2020-07-14 | Ivantis, Inc. | Ocular implant delivery system and method |
US9844556B2 (en) | 2015-03-25 | 2017-12-19 | Megumi Honjo | Preventive/therapeutic method and preventive/therapeutic agent for complications after cataract surgery |
JP6837475B2 (ja) | 2015-08-14 | 2021-03-03 | イバンティス インコーポレイテッド | 圧力センサを備えた眼用インプラントおよび送達システム |
US20180296474A1 (en) | 2015-10-13 | 2018-10-18 | INSERM (Institut National de la Santé et de la Recherche Médicale | Methods and pharmaceutical compositions for the treatment of retinal capillary non-perfusion |
EP4088719A1 (de) | 2015-10-13 | 2022-11-16 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Verfahren und pharmazeutische zusammensetzungen zur behandlung von kapillarer nichtperfusion der netzhaut |
WO2017106517A1 (en) * | 2015-12-15 | 2017-06-22 | Ivantis, Inc. | Ocular implant and delivery system |
EP4338751A2 (de) | 2017-12-21 | 2024-03-20 | Santen Pharmaceutical Co., Ltd. | Arzneimittel mit einer kombination aus sepetaprost und rho-assoziiertem coiled-coil mit einem proteinkinasehemmer |
JP2023516891A (ja) | 2020-02-05 | 2023-04-21 | ニコックス エス.エー. | 緑内障及び高眼圧症の処置のための組成物 |
AU2022205382A1 (en) | 2021-01-11 | 2023-06-22 | Alcon Inc. | Systems and methods for viscoelastic delivery |
KR20230157307A (ko) | 2021-01-11 | 2023-11-16 | 인사이트 코포레이션 | Jak 경로 억제제 및 rock 억제제를 포함하는 병용 요법 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4838677A (en) | 1987-04-06 | 1989-06-13 | Ayetech Inc. | Eye exercising devices |
US5250547A (en) * | 1991-08-29 | 1993-10-05 | Syntex (U.S.A.) Inc. | Benzopyran derivatives |
EP0641781B1 (de) | 1991-09-06 | 2000-07-26 | Yoshitomi Pharmaceutical Industries, Ltd. | 4-amino(alkyl)cyclohexan-1-carboxamidverbindungen und ihre verwendung |
IL104755A0 (en) | 1992-02-17 | 1993-06-10 | Ciba Geigy Ag | Treatment of glaucoma |
IL103932A (en) * | 1992-11-30 | 1997-02-18 | Yissum Res & Dev | Fatty acid and pharmaceutical compositions containing them |
US5618955A (en) | 1992-11-30 | 1997-04-08 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Fatty acid derivatives and pharmaceutical compositions containing same |
JP3066561B2 (ja) * | 1993-10-07 | 2000-07-17 | 武田薬品工業株式会社 | 近視予防・治療剤 |
JPH07133225A (ja) * | 1993-11-09 | 1995-05-23 | Santen Pharmaceut Co Ltd | 毛様体筋緊張緩和剤 |
EP1195372A1 (de) | 1994-04-18 | 2002-04-10 | Mitsubishi Pharma Corporation | N-Heterozyklisch substitutierte Benzamid Deriviate mit antihypertensiver Wirkung |
JPH08198876A (ja) * | 1995-01-30 | 1996-08-06 | Yoshitomi Pharmaceut Ind Ltd | トランス−N−(1H−ピラゾロ〔3,4−b〕ピリジン−4−イル)−4−グアニジノメチルシクロヘキサンカルボキサミド・1メタンスルホン酸塩・1水和物 |
US5888173A (en) | 1995-08-10 | 1999-03-30 | Singhal; Tara Chand | Health saver computer break |
US5906819A (en) | 1995-11-20 | 1999-05-25 | Kirin Beer Kabushiki Kaisha | Rho target protein Rho-kinase |
JP3421217B2 (ja) * | 1995-11-20 | 2003-06-30 | 麒麟麦酒株式会社 | Rho標的タンパク質Rhoキナーゼ |
JPH09143099A (ja) * | 1995-11-27 | 1997-06-03 | Santen Pharmaceut Co Ltd | 毛様体筋緊張緩和剤 |
AU720326B2 (en) | 1995-12-21 | 2000-05-25 | Alcon Laboratories, Inc. | Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia |
US5798380A (en) * | 1996-02-21 | 1998-08-25 | Wisconsin Alumni Research Foundation | Cytoskeletal active agents for glaucoma therapy |
JPH10203982A (ja) * | 1996-07-05 | 1998-08-04 | Takeda Chem Ind Ltd | 視機能障害の予防・治療剤 |
SI0956865T2 (sl) * | 1996-08-12 | 2011-04-29 | Mitsubishi Pharma Corp | Zdravila, ki obsegajo inhibitor Rho-kinaze |
-
1999
- 1999-08-13 EP EP04014078A patent/EP1459743B9/de not_active Expired - Lifetime
- 1999-08-13 ES ES99937073T patent/ES2247822T3/es not_active Expired - Lifetime
- 1999-08-13 EP EP04014077A patent/EP1459742B9/de not_active Expired - Lifetime
- 1999-08-13 US US09/529,354 patent/US6673812B1/en not_active Expired - Lifetime
- 1999-08-13 ES ES04014077T patent/ES2374518T3/es not_active Expired - Lifetime
- 1999-08-13 CN CNB998018732A patent/CN1195547C/zh not_active Expired - Fee Related
- 1999-08-13 ES ES04014078T patent/ES2372572T3/es not_active Expired - Lifetime
- 1999-08-13 AT AT04014078T patent/ATE529102T1/de not_active IP Right Cessation
- 1999-08-13 JP JP2000564663A patent/JP3720264B2/ja not_active Expired - Fee Related
- 1999-08-13 KR KR1020007004051A patent/KR100616466B1/ko not_active IP Right Cessation
- 1999-08-13 CN CNB2003101142105A patent/CN1293878C/zh not_active Expired - Fee Related
- 1999-08-13 AT AT99937073T patent/ATE307609T1/de not_active IP Right Cessation
- 1999-08-13 WO PCT/JP1999/004403 patent/WO2000009162A1/ja active IP Right Grant
- 1999-08-13 AT AT04014077T patent/ATE527993T1/de not_active IP Right Cessation
- 1999-08-13 CA CA002307285A patent/CA2307285C/en not_active Expired - Fee Related
- 1999-08-13 EP EP99937073A patent/EP1034793B1/de not_active Expired - Lifetime
- 1999-08-13 AU AU51981/99A patent/AU5198199A/en not_active Abandoned
- 1999-08-13 DE DE69927936T patent/DE69927936T2/de not_active Expired - Lifetime
- 1999-08-13 CA CA2635412A patent/CA2635412C/en not_active Expired - Fee Related
-
2001
- 2001-03-12 HK HK05102430.9A patent/HK1069120A1/xx not_active IP Right Cessation
- 2001-03-12 HK HK05102431.8A patent/HK1069121A1/xx not_active IP Right Cessation
- 2001-03-12 HK HK01101779A patent/HK1030883A1/xx not_active IP Right Cessation
-
2002
- 2002-11-19 US US10/298,674 patent/US6649625B2/en not_active Expired - Fee Related
-
2004
- 2004-07-06 JP JP2004199836A patent/JP4490748B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69927936D1 (de) | Präventiva/mittel zur glaukombehandlung | |
PT868186E (pt) | Utilizacao de certos compostos de isoquinolinossulfonilo para tratamento de glaucoma e isquemia ocular | |
WO2002083064A3 (en) | A method of treating cancer | |
NO941937L (no) | Sakarinderivater som inhiberer proteolytiske enzymer | |
WO2007076367A3 (en) | Rnai-mediated inhibition of rho kinase for treatment of ocular hypertension / glaucoma | |
WO2002098350A3 (en) | Pyranoindazoles and their use for the treatment of glaucoma | |
BR0113740A (pt) | Nitrilas espiroheterocìclicas úteis como inibidores reversìveis de proteases de cisteìna | |
NO20053263D0 (no) | Hydroksyetylaminderivater for behandling av Alzheimers sykdom. | |
CY1108651T1 (el) | Προληπτικος ή θεραπευτικος παραγων για γλαυκωμα | |
PT1263504E (pt) | Compostos com actividade 5-ht1a uteis para o tratamento de perturbacoes da retina externa | |
WO2007120817A3 (en) | Methods and compositions for the treatment of infection or infectious colonization of the eyelid, ocular surface, skin or ear | |
BR0017157A (pt) | Derivados de 6-hidroxi-indazol para o tratamento de glaucoma | |
WO2003005941A3 (de) | Insert zur behandlung des trockenen auges | |
TR200003279T2 (tr) | Vitreo-retinal cerrahi için prosedürlerin kolaylaştırılması için bir vital boyanın kullanımı | |
BR0210238A (pt) | Novos análogos de aril-amino-propano e seu uso para o tratamento de glaucoma | |
AU2001288053A1 (en) | N-substituted benzothiophenesulfonamide derivatives | |
WO2005014576A8 (ja) | イソキノリノン誘導体、その製造法および用途 | |
WO2003013499A3 (en) | Drugs for vasculopaties | |
WO2003028652A3 (en) | Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis | |
WO2003101379A3 (en) | Pyranoindazoles and their use for the treatment of glaucoma | |
WO2000027376A3 (de) | Verwendung von thiolverbindungen, oxidoreduktasen und/oder hydrolasen zur behandlung des tinnitus, insbesondere des chronischen tinnitus | |
WO2022235551A3 (en) | Fc-fusion protein therapeutic for the treatment of pancreatitis | |
WO2001035948A3 (en) | Neurophilin ligands for treating ocular conditions | |
WO2002023784A3 (en) | Cysteine protease inhibitors | |
DK0946503T3 (da) | Nitromethylthiobenzenderivater som inhibitorer for aldosereductase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |